InMed Pharmaceuticals (INM) Change in Acquisitions & Divestments (2023 - 2025)
Historic Change in Acquisitions & Divestments for InMed Pharmaceuticals (INM) over the last 3 years, with Q3 2025 value amounting to $20957.0.
- InMed Pharmaceuticals' Change in Acquisitions & Divestments fell 172.11% to $20957.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $41903.0, marking a year-over-year decrease of 44.19%. This contributed to the annual value of $42270.0 for FY2025, which is 44.67% up from last year.
- Per InMed Pharmaceuticals' latest filing, its Change in Acquisitions & Divestments stood at $20957.0 for Q3 2025, which was down 172.11% from $2231.0 recorded in Q2 2025.
- In the past 5 years, InMed Pharmaceuticals' Change in Acquisitions & Divestments registered a high of $21324.0 during Q3 2024, and its lowest value of -$431.0 during Q2 2024.
- In the last 3 years, InMed Pharmaceuticals' Change in Acquisitions & Divestments had a median value of $18497.0 in 2025 and averaged $13163.6.
- The largest annual percentage gain for InMed Pharmaceuticals' Change in Acquisitions & Divestments in the last 5 years was 61763.34% (2025), contrasted with its biggest fall of 2433.95% (2025).
- Over the past 3 years, InMed Pharmaceuticals' Change in Acquisitions & Divestments (Quarter) stood at $21317.0 in 2023, then crashed by 87.44% to $2678.0 in 2024, then skyrocketed by 682.56% to $20957.0 in 2025.
- Its last three reported values are $20957.0 in Q3 2025, $2231.0 for Q2 2025, and $16037.0 during Q1 2025.